Switch to PDF viewer

Back to Collection

Pharmafile

Welcome to issue 72 of Pharmafile, covering topics such as antimicrobial resistance, rare diseases and skin conditions

redbow consulting

Somewhere over the redbow, you will find...

Contents

Therapeutic Areas in Focus

Charting the course to 2022

Editorial Assistant, Ana Ovey introduces the edition, exploring some of the key themes and topics emerging in the issue.

Pharma Times

The 2022 International Clinical Researcher of the Year competition is open for entry!

Deep down inside: How AI is supporting new therapeutic combinations

Pharmafile speaks to DeepDrug: DeepDrug tells Pharmafile about the development of new drugs for neglected and infectious diseases, including how AI can be used in the drug development process

Resisting change: The pathway to better AMR planning

Following a global survey on antimicrobial resistance, a global plan has been initiated by WHO, this article explores the further steps that can be taken in AMR planning

A bold & ambitious plan: Harnessing data and improving health & care continuity for the next decade

Health data systems can be used to directly help patients engage with their care and build trust with their HCPs, this article explores these strategies, placing patient outcomes at the centre of care

Redbow Consulting Group

Redbow explains their healthcare consultancy strategy and shares details about the company

Delivering transformational data analysis for infectious disease drug discovery

AI can help infectious diseases remain in the spotlight and help them gain interest from R&D investors, this article explains how

Supporting rare neurological disease patients during COVID-19

PHARMAFILE SPEAKS TO The Brain Charity: The Brain Charity explain how they've been providing support to patients with rare diseases throughout the COVID-19 pandemic

Treatable, untreatable, undetermined: Overcoming rare disease

Ipsen tells Pharmafile about the underestimated impacts of rare and ultra-rare diseases

Pharmafile

Pharmafile: Global Pharmaceutical Webinars

Rare disease and orphan medicines – Will gover nment policy change the paradigm?

Rare and ultra-rare diseases impact a surprising amount of people, this article explores the field of rare diseases as well as the diagnostic journey many patients take

Every number has a face: Are you valuing the patient voice?

Patients play an important but often forgotten role in drug development, this article considers the significance of patient experience while developing treatments

Not so rare diseases: The cumulative burden of underdiagnosis

A lack of research, funding and representation for rare diseases can lead to under diagnosis, this article looks to the future of rare disease treatments

Scratching the surface of eczema care in the UK

Pharmafilespeaks to Allergy UK: Allergy UK explores the future of eczema diagnosis, treatment, and support

PME

PME: Pharmaceutical Market Europe: Make sure you always have access to your copy of PME!

‘Cumulative life course impairment’: The unforeseen burdens of severe eczema

Skin diseases have many impacts on patients' lives, AbbVie explores these impacts

Dermatologically speaking: Finding new treatments for women

Organon discusses the ways in which women's skin conditions can be managed

Insight and oversight: Making the most of virtual platforms in dermatology

FIDE discuss the need for communication between patients and their HCPs, specifically with virtual platforms in mind, and how this can improve dermatology care

“The pain keeps me awake at night. I can’t cope with this anymore”

There have been significant advances in dermatological care, this article explores this as well as looking forward to what still needs to be done

Supporting dermatology and oncology services to build back better post-COVID-19

The COVID-19 pandemic has been challenging service-wide for the NHS, but the pharma industry can support patients and the NHS going forward

SAMEDAN

Samedan Ltd: Covering every stage of the supply chain

ICON

ICON: Antimicrobial Resistance: How clinical research can combat an ensuing global crisis

Pharmafile

Therapeutic areas in focus

Therapeutic areas in focus Volume 72 Autumn 2021

Antimicrobial resistance

Governments and global organisations continue to play a pivotal role in developing and enforcing plans against AMR

The rare disease spectrum

People suffering from rare and ultra-rare diseases must be better supported to overcome their unique daily obstacles

Approaching eczema in 2022

Patients with skin conditions face significant challenges in their personal and professional lives, but what can be done to address these?

In affiliation with Pharmafocus